Patent Filing

A new US patent allowance for Purple Biotech's modular CAPTN-3 platform bolsters its strategic position, promising safer, more precise antibody cancer treatments.

With a new patent, a bold asset pivot, and a top-tier banking partner, PharmAla Biotech is signaling a new phase of commercial maturity in psychedelic medicine.

A new patent for an 'evolving' digital ID promises to fight fraud and boost financial inclusion. But what does a continuous identity profile mean for us?

A New Hampshire firm just patented a high-tech vacuum. It seems mundane, but it reveals a deep strategy for dominance in advanced manufacturing.

A new patent for its E-Motion™ powertrain isn't just about IP; it's a strategic move to lock down safety, secure OEM deals, and define the future.

A new composition of matter patent extends protection for Alterity's lead drug to 2045, de-risking its path in MSA and opening a new front against Parkinson's.

A new patent allows securities to exist as both ETF shares and digital tokens, with giants like HSBC already on board. Is this the end of digital chaos?

With new patents and a $300M war chest, Beren Therapeutics nears an FDA decision for its NPC drug. But can its public benefit model survive the high-risk biotech gauntlet?

A Mobile startup’s fourth patent for a surgical device isn't just an innovation; it's proof that Alabama's strategic investment in tech is building a new economy.

Proto Inc.'s new design patent for its M hologram unit is more than just IP. It's a strategic move to define the form factor for a new era of work.

New patents in Europe and Australia grant Savara long-term protection for a vital new therapy, offering hope to patients with a rare, debilitating lung disease.

Two small firms just secured a patent until 2045 on a decades-old drug. It's a masterclass in strategy, revealing the future of pharmaceutical value.

Pilot Games' new patent for e-pull-tabs isn't just a tech upgrade; it's a strategic move in a billion-dollar market where IP is the ultimate jackpot.

A series of decisive legal victories in the U.S. and Europe has given food giant Danone a powerful grip on the future of a key gut health microbe.

A Virginia tech firm patented a 'living trust profile' you control. Will this kill data fatigue and protect firms from breaches, or create new digital divides?

SOTIO Biotech's European patent win for its immunocytokine SOT201 wasn't just a legal victory; it's a signpost in the fierce race to redefine cancer care.

Celebrating its 200th patent, Route 92 Medical isn't just advancing stroke care; it's building an IP fortress to challenge industry giants.

Curative Biotechnology secures a key U.S. patent for a metformin eye-drop, a novel approach that could transform treatment for macular degeneration.

A mining firm just secured a key gene therapy patent for ALS. Timothy Bell dissects the audacious strategy of funding cutting-edge biotech with Greenland's mineral wealth.

Amplia Therapeutics' new patent application for novel FAK inhibitors extends protection to 2046, signaling a major play in oncology and fibrosis markets.